Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Call for more research to prevent racehorse injury
racehorses
Owners and trainers want more research to focus on preventing tendon injuries.

University of Glasgow meeting hears prevention better than cure

More research should be done on the factors involved in tendon injury to help prevent the condition in racehorses, a meeting organised by the University of Glasgow has heard.

Horse owners and trainers say they would like more help in preventing the costly injury, which can easily end a champion's career, with prevention rather than cure being the area that researchers should focus on, according to the meeting, held to discuss a study into superficial digital flexor tendon injuries. These injuries are both exercise and age-related and affect up to 30 per cent of thoroughbred racehorses, with similarities to Achilles tendon injuries in human athletes.

Despite apparent advances in stem cell techniques to repair damaged tendons in horses, trainers and owners say they would like more help preventing the injury in the first place, and would prefer that this is where researchers focus their attention.

Tendon injuries are slow-healing and can easily recur, effectively ending the racing career of many horses.

The difficulty lies in early diagnosis of superficial digital flexor tendon injury as, while there are various degrees of damage before the tendon ruptures, and before the horse is visibly lame, there is currently no simple test that can be carried out to find this damage in its earliest stages. Once a tendon weakens to the point that it ruptures, it will never be the same again.

Professor Janet Patterson-Kane, professor of veterinary pathology, said: “What researchers are focusing on is not necessarily what people want. We thought they would be interested in stem-cell therapy and suchlike, but they’d rather not have to spend large amounts of money on treatments in the first place. Prevention, however, could make a bigger difference – for example, there have been success stories in general injury prevention through paying attention to things like race surfaces and animal welfare."

Lincolnshire-based racehorse trainer and vet James Given, who contributed his views to the study, said: “The superficial digital flexor tendon is a fairly common injury – we probably see a couple of horses here every year or so with it. Some horses do come back from it to race again, but I think most trainers feel that once an injury has occurred it’s certainly a career-limiting event, if not career-ending.

“There are many treatments used for this condition but no single one seems to be better than another. If scientists were able to identify a biomarker within a blood sample that indicated the tendon was breaking down it would allow early preventative intervention. It would be very helpful.”

Finding a way to obtain early warning of tendon damage may also benefit to human athletes too. Prof Patterson-Kane said: “Achilles tendon injuries for athletes are increasingly common and once injured, they re-injure very easily, putting an end to many careers. Nevertheless, the focus of research remains on treatment rather than prevention because it is seen as easier. But it doesn’t mean to say that’s what we should be concentrating on.”

The study, funded by the Biotechnology and Biological Sciences Research Council and published in the Equine Veterinary Journal, suggests there should be research to further identify factors involved in tendon injury, links between training regimens early in life and subsequent performance, and the development of imaging and blood testing strategies for the detection of early signs of injury.

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'